Pharmaceutical Products and IV Fluids Supplementary Tender 003

⁠⁠⁠Notice of upcoming tender:

HPVITS2019-058.003 – Pharmaceutical Products and IV Fluids Supplementary 003

Scope:

Subcategory number                   Subcategory name
517.01                               Arsenic trioxide 10mg/10mL injection, ampoule/vial,10mL

83001.01                           Bevacizumab 100mg/4mL injection, ampoule/vial, 4mL

83001.02                           Bevacizumab 400mg/16mL injection, ampoule/vial, 16mL

518.01                               Bortezomib injection, ampoule/vial

519.01                               Cabazitaxel 60mg injection, ampoule/vial

527.01                               Carmustine 100mg injection, ampoule/vial

520.01                               Daptomycin 350mg injection, ampoule/vial

520.02                               Daptomycin 500mg injection, ampoule/vial

521.01                               Deferasirox 90mg tablet/capsule 30

521.02                               Deferasirox 180mg tablet/capsule 30

521.03                               Deferasirox 360mg tablet/capsule 30

522.01                               Desflurane 1mL/1mL or 1g/1g Inhalation solution, bottle 250mL

197.03                               Furosemide (Frusemide) 20mg/2mL injection, ampoule/vial, 2mL

523.01                               Imatinib 100mg tablet/capsule 30 (GIST indication)

523.02                               Imatinib 100mg tablet/capsule 30 (non-GIST indication)

523.03                               Imatinib 400mg tablet/capsule 60 (GIST indication)

523.04                               Imatinib 400mg tablet/capsule 60 (non-GIST indication)

524.01                               Methylprednisolone (sodium succinate) 500mg injection, ampoule/vial

524.02                               Methylprednisolone (sodium succinate) 1g injection, ampoule/vial

325.02                               Moxifloxacin 400mg tablet/capsule 5

525.01                               Oseltamivir 30mg capsule 10

525.02                               Oseltamivir 45mg capsule 10

525.03                               Oseltamivir 75mg capsule 10

526.01                               Sodium nitroprusside 50mg/2mL injection, ampoule/vial, 2mL

499.04                               Vancomycin 500mg injection, ampoule/vial 

Market Release Date: 01 March 2021

All enquiries regarding this supplementary tender prior to the market release date should be directed to r.luong@healthsharevic.org.au or (03)99473933 . Once the tender has been released, please direct all correspondence through the HSV Procurement Portal.